E-Bikes Vroom Forward
Health Care: Drugs
Arqule Inc. (ARQL: NASDAQ)
$2.78 0.00 | 0.00%
05/21/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 59,125 | 64,499 | 64,194 | 6,629 | 2,757 | 2,796 | 17,012 |
| Shares Bought | 69,991 | 75,365 | 75,060 | 6,629 | 2,757 | 2,796 | 17,012 |
| Shares Sold | 10,866 | 10,866 | 10,866 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 34.92M | 37.20M | 38.23M | 39.12M | 43.50M | 41.35M | 40.86M |
| Shares Bought | 5.89M | 9.23M | 11.52M | 11.51M | 8.82M | 6.04M | 6.59M |
| Shares Sold | 19.48M | 18.56M | 17.73M | 17.93M | 8.48M | 10.83M | 11.70M |
Portfolios with ARQL
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserD-ZYRE
- User2012 picks 10/28/20121
- ContributorBreakout Stocks Of The Week...
- Contributor22 Biopharma Stocks With Br...
Latest ARQL Headlines from TheStreet
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- 5 Under-$10 Stocks Setting Up to Trade Higher 11.30.12 | 12:11 pm
- 5 Stocks Poised for Breakouts 10.26.12 | 01:10 pm
- Stocks Drop on Eurozone, Earnings Anxieties 10.02.12 | 02:10 pm
- Arqule Shutters Lung Cancer Study Early Due to Futility 10.02.12 | 07:10 am
- Arqule Shares Slide on Lung Cancer Drug Safety Concern 08.29.12 | 10:08 am
- ASCO 2012 Live Blog -- Saturday 06.02.12 | 07:06 am
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update) 05.17.12 | 06:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus 05.16.12 | 06:05 pm
Press Releases for ARQL
- ArQule Reports Fiscal 2012 Year End And Fourth Quarter Results - Business Wire 03.14.13 | 07:03 am
- ArQule To Report Fiscal 2012 Financial Results On March 14, 2013 - Business Wire 03.07.13 | 08:03 am
- ArQule, Inc. To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- ArQule, Inc. To Present At RBC Capital Markets Global Healthcare Conference - Business Wire 02.19.13 | 08:02 am
- ArQule, Inc. To Present At Leerink Swann Global Healthcare Conference - Business Wire 02.07.13 | 08:02 am
- Daiichi Sankyo And ArQule Enroll First Hepatocellular Carcinoma Patient Into Global Phase 3 Trial For Tivantinib - Business Wire 01.31.13 | 08:01 am
- Daiichi Sankyo And ArQule Announce Top-Line Results Of Phase 2 Trial With Tivantinib In Colorectal Cancer - Business Wire 01.11.13 | 07:01 am
- ArQule Enrolls First Patient In Phase 1 Trial With ARQ 087, An FGFR Inhibitor - Business Wire 12.13.12 | 08:12 am
- ArQule, Inc. To Present At Oppenheimer Healthcare Conference - Business Wire 12.05.12 | 04:12 pm
- ArQule, Inc. To Present At Lazard Healthcare Conference - Business Wire 11.07.12 | 08:11 am
Partner Headlines for ARQL
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.03.12 | 09:10 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 08.07.12 | 09:08 am
- Teradyne DROPS 16% in Recent Weeks and 4 Fresh Analyst Insights - Wall St. Cheat Sheet 07.06.12 | 01:07 pm
- Five Stocks With Heavy Insider Trading - Benzinga 06.11.12 | 01:06 pm
- Stock Insights: Dendreon, Medtronic, FedEx, ArQule, Rentrak June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- ArQule Announces Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma - Benzinga 06.02.12 | 06:06 pm
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.01.12 | 09:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.02.12 | 09:04 am
- Company News for January 18, 2012 - Corporate Summary - Zacks 01.18.12 | 10:01 am
